Home - Products - Others - Other Targets - Methyl 2,4-dihydroxyphenylacetate

Methyl 2,4-dihydroxyphenylacetate

CAS No. 67828-42-6

Methyl 2,4-dihydroxyphenylacetate( —— )

Catalog No. M28968 CAS No. 67828-42-6

Methyl 2,4-dihydroxyphenylacetate is a natural product isolated from Nigella damascena seeds with selective phytotoxic effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
10MG 42 In Stock
25MG 67 In Stock
50MG 91 In Stock
100MG 138 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl 2,4-dihydroxyphenylacetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl 2,4-dihydroxyphenylacetate is a natural product isolated from Nigella damascena seeds with selective phytotoxic effects.
  • Description
    Methyl 2,4-dihydroxyphenylacetate is a natural product isolated from Nigella damascena seeds with selective phytotoxic effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PARP1|ARTD-1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    67828-42-6
  • Formula Weight
    182.175
  • Molecular Formula
    C9H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (548.94 mM)
  • SMILES
    COC(=O)Cc1ccc(O)cc1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Haikarainen T, et al. Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors.ACS Med Chem Lett.?2013?Nov 20;5(1):18-22.
molnova catalog
related products
  • Maleic acid disodium...

    Maleic acid disodium salt is a pharmaceutical intermediate used in the synthesis of other active compounds.

  • Norswertianolin

    Norswertianolin, a compound isolated from G. acuta, functions as a CSE activator and shows promise as a potential cardiovascular therapeutic.

  • Sari 59-801

    Sari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).